| Phase 4 |
| NCT07728097 |
A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment… |
Lennox-Gastaut Syndrome |
Not Yet Recruiting |
2026-09-24 |
| NCT05044819 |
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex… |
Lennox Gastaut Syndrome |
Active, Not Recruiting |
2026-08-26 |
| Phase 3 |
| NCT06282575 |
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care… |
Biliary Tract Cancer |
Recruiting |
2026-09-14 |
| NCT07625280 |
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in… |
Narcolepsy |
Recruiting |
2026-08-19 |
| NCT05580562 |
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) |
H3 K27M |
Recruiting |
2026-04-16 |
| NCT06435429 |
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in… |
Metastatic HER2-positive Breast Cancer |
Recruiting |
2026-02-10 |
| NCT05152147 |
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in… |
Gastric Neoplasms |
Active, Not Recruiting |
2026-09-24 |
| NCT07723976 |
A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE |
Developmental and Epileptic Encephalopathy (DEE) |
Not Yet Recruiting |
2026-07-24 |
| Phase 2/3 |
| NCT07723963 |
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of… |
Juvenile Myoclonic Epilepsy |
Not Yet Recruiting |
2026-09-02 |
| Phase 2 |
| NCT07102381 |
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in… |
HER2-positive Breast Cancer |
Recruiting |
2026-10-01 |
| NCT07459634 |
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants… |
Extensive-stage Small-cell Lung Cancer |
Recruiting |
2026-09-17 |
| NCT07533942 |
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma |
Meningioma |
Recruiting |
2026-07-30 |
| NCT06695845 |
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors |
Breast Cancer |
Recruiting |
2026-07-10 |
| NCT07282587 |
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma |
Advanced Pheochromocytoma and Paraganglioma |
Recruiting |
2026-06-10 |
| Phase 1/2 |
| NCT05734066 |
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With… |
Refractory Ewing Sarcoma |
Recruiting |
2026-02-03 |
| Phase 1 |
| NCT07233239 |
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS… |
Focal Seizures |
Recruiting |
2026-08-11 |
| NCT07377539 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of… |
Healthy Participants |
Recruiting |
2026-04-20 |
| NCT04541082 |
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System… |
Central Nervous System Neoplasms |
Recruiting |
2025-12-18 |
| NCT06108050 |
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults… |
Advanced Solid Tumor |
Recruiting |
2025-12-16 |
| NCT05557045 |
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid… |
Advanced Cancer |
Active, Not Recruiting |
2026-09-10 |
| NCT07813663 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… |
Healthy Participants |
Not Yet Recruiting |
2026-09-10 |
| Not specified |
| NCT06113237 |
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy |
Maternal Complications |
Recruiting |
2026-08-20 |
| NCT07780968 |
Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA |
Esophageal Cancer |
Not Yet Recruiting |
2026-08-25 |
| NCT05772429 |
Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a… |
Seizures |
Active, Not Recruiting |
2026-06-15 |
| NCT05485831 |
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an… |
Lennox Gastaut Syndrome |
Active, Not Recruiting |
2026-06-03 |